Philippe De Donder, Bertrand Achou, Franca Glenzer, Minjoon Lee, and Marie-Louise Leroux, “Nursing home aversion post-pandemic: Implications for savings and long-term care policy”, TSE Working Paper, n. 21-1249, September 2021.
Catarina Goulão, and Agustín Pérez-Barahona, “Health aspirations and the epidemic of non-communicable chronic diseases”, TSE Working Paper, n. 21-1236, July 2021, revised June 2023.
David Bardey, Arturo Harker, and Daniela Zuluaga, “Price cap regulation in the Colombian pharmaceutical market: An impact evaluation”, TSE Working Paper, n. 21-1195, March 2021.
David Bardey, Manuel Fernandez, and Alexis Gravel, “Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run?”, TSE Working Paper, n. 21-1189, February 2021.
James K. Hammitt, and Nicolas Treich, “Fatality Risk Regulation”, TSE Working Paper, n. 21-1177, January 2021.
James K. Hammitt, “Valuing mortality risk in the time of covid-19”, TSE Working Paper, n. 20-1115, June 2020.
James K. Hammitt, “Accounting for the distribution of benefits & costs in benefit-cost analysis”, TSE Working Paper, n. 20-1116, June 2020.
Christian Gollier, “If the objective is herd immunity, on whom should it be built?”, Covid Economics, n. 16, May 2020, pp. 98–114.
Christian Gollier, and Olivier Gossner, “Group testing against Covid-19”, Covid Economics, n. 1, n. 2, April 2020, pp. 32–42.
Pierre Dubois, Paulo Albuquerque, Oliver Allais, Céline Bonnet, Patrice Bertail, P. Compris, Saadi Lahlou, Nathalie Rigal, Bernard Ruffieux, and Pierre Chandon, “Effects of front-of-pack labels on the nutritional quality of supermarket food purchases: evidence from a large-scale randomized controlled trial”, TSE Working Paper, n. 20-1088, April 2020.